Loading...
The University of Chicago Header Logo
Keywords
Last Name
Institution

Loren Saulsberry

TitleAssistant Professor
InstitutionUniversity of Chicago
DepartmentPublic Health Sciences
AddressChicago IL 60637
Email
vCardDownload vCard

    Collapse Overview 
    Collapse overview
    Loren Saulsberry is the Assistant Program Leader of the Cancer Prevention and Control Program within the UChicago Medicine Comprehensive Cancer Center and the Assistant Director of Diversity Studies in the UChicago Center for Personalized Therapeutics. As a health policy and health services researcher, Dr. Saulsberry investigates the experiences of vulnerable populations managing chronic conditions, especially those underrepresented and medically underserved. Her research interests include: (1) health policies and services that impact precision medicine delivered across the care continuum from prevention and early detection to cancer outcomes, (2) the relationships between politics and health communication, (3) the determinants contributing to health disparities affecting diverse populations, especially across race/ethnicity and socioeconomic status.


    Collapse Biography 
    Collapse education and training
    Harvard University , Boston, MAPh.D. 05/2017Health Policy
    Wellesley College, Wellesley, MAB.A.05/2010Neuroscience, English
    Collapse awards and honors
    2020 - 2022Human Genetics Scholar, American Society of Human Genetics (ASHG)
    2022K Award, Central Society for Clinical and Translational Research (CSCTR)
    2019North Coast Conference on Precision Medicine Travel Award, Cleveland Institute for Computational Biology, Case Western Reserve University

    Collapse ORNG Applications 
    Collapse Featured Presentations
    Collapse Featured Videos
    Collapse Websites

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Saulsberry L, Olopade OI. Shifting the Paradigm: Reimagining Approaches to Diversifying the Leadership of the Nation's Cancer Centers. J Natl Cancer Inst. 2022 Jul 28. PMID: 35897142.
      View in: PubMed
    2. Saulsberry L, Singh L, Pruitt J, Ward C, Wake DT, Gibbons RD, Meltzer DO, O'Donnell PH, Cruz-Knight W, Hulick PJ, Dunnenberger HM, David SP. Effect Modification by Social Determinants of Pharmacogenetic Medication Interactions on 90-Day Hospital Readmissions within an Integrated U.S. Healthcare System. J Pers Med. 2022 Jul 15; 12(7). PMID: 35887642.
      View in: PubMed
    3. Saulsberry L, Danahey K, Middlestadt M, O'Leary KJ, Nutescu EA, Chen T, Lee JC, Ruhnke GW, George D, House L, van Wijk XMR, Yeo KJ, Choksi A, Hartman SW, Knoebel RW, Friedman PN, Rasmussen LV, Ratain MJ, Perera MA, Meltzer DO, O'Donnell PH. Applicability of Pharmacogenomically Guided Medication Treatment during Hospitalization of At-Risk Minority Patients. J Pers Med. 2021 Dec 10; 11(12). PMID: 34945816.
      View in: PubMed
    4. Saulsberry L, Danahey K, Borden BA, Lipschultz E, Traore M, Ratain MJ, Meltzer DO, O'Donnell PH. Underrepresented patient views and perceptions of personalized medication treatment through pharmacogenomics. NPJ Genom Med. 2021 Nov 01; 6(1):90. PMID: 34725343.
      View in: PubMed
    5. Saulsberry L, Liao C, Huo D. Hypofractionated Radiation Therapy for Breast Cancer: Financial Risk and Expenditures in the United States, 2008 to 2017. Int J Radiat Oncol Biol Phys. 2022 03 01; 112(3):654-662. PMID: 34637883.
      View in: PubMed
    6. Kacew AJ, Strohbehn GW, Saulsberry L, Laiteerapong N, Cipriani NA, Kather JN, Pearson AT. Artificial Intelligence Can Cut Costs While Maintaining Accuracy in Colorectal Cancer Genotyping. Front Oncol. 2021; 11:630953. PMID: 34168975.
      View in: PubMed
    7. Kang MM, Hasan Y, Waller J, Saulsberry L, Huo D. Has Hypofractionated Whole-Breast Radiation Therapy Become the Standard of Care in the United States? An Updated Report from National Cancer Database. Clin Breast Cancer. 2022 01; 22(1):e8-e20. PMID: 34257001.
      View in: PubMed
    8. Saulsberry L, Olopade OI. Precision oncology: Directing genomics and pharmacogenomics toward reducing cancer inequities. Cancer Cell. 2021 06 14; 39(6):730-733. PMID: 34019805.
      View in: PubMed
    9. Saulsberry L, Peek M. Financing Diabetes Care in the U.S. Health System: Payment Innovations for Addressing the Medical and Social Determinants of Health. Curr Diab Rep. 2019 11 20; 19(11):136. PMID: 31748950.
      View in: PubMed
    10. Saulsberry L, Seo V, Fung V. The Impact of Changes in Medicaid Provider Fees on Provider Participation and Enrollees' Care: a Systematic Literature Review. J Gen Intern Med. 2019 10; 34(10):2200-2209. PMID: 31388912.
      View in: PubMed
    11. Saulsberry L, Fowler EF, Nagler RH, Gollust SE. Perceptions of politicization and HPV vaccine policy support. Vaccine. 2019 08 14; 37(35):5121-5128. PMID: 31296376.
      View in: PubMed
    12. Saulsberry L, Pace LE, Keating NL. The Impact of Breast Density Notification Laws on Supplemental Breast Imaging and Breast Biopsy. J Gen Intern Med. 2019 08; 34(8):1441-1451. PMID: 31144277.
      View in: PubMed
    13. Saulsberry L, Blendon RJ, Benson JM. . Challenges confronting African Americans and Hispanics living with chronic illness in their families. Chronic Illness. 2016; 4(12):281-291.
    14. Saulsberry L, Price M, Hsu J. . Insurance coverage & Whither Thou Goest for health information in 2012. Medicare Medicaid Res Rev. 2014; 4(4):E1-E23.
    Saulsberry's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    _
    Co-Authors Expand Description
    _
    Similar People Expand Description
    _
    Same Department Expand Description
    Physical Neighbors Expand Description
    _